Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Neovasc Stock Price
Symbol:
TSX:NVCN
·
Market Cap:
CA$110.8m
·
Category:
Healthcare
NVCN Share Price Performance
NVCN Community Fair Values
JO
Jolt_Communications
Community Contributor
The Future of Drug Testing? Fingerprint Tech Shows Serious Promise
Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
US$2.98
FV
43.0% undervalued
intrinsic discount
59.20%
Revenue growth p.a.
10
users have liked this narrative
0
users have commented on this narrative
57
users have followed this narrative
about 1 month ago
author updated this narrative
View all narratives
Recent NVCN News & Updates
No updates
Neovasc Inc. Competitors
Izotropic
Symbol:
CNSX:IZO
Market cap:
CA$16.8m
TripSitter Clinic
Symbol:
CNSX:KETA
Market cap:
CA$366.2k
Newtopia
Symbol:
TSXV:NEWU
Market cap:
CA$866.3k
Revitalist Lifestyle and Wellness
Symbol:
CNSX:CALM
Market cap:
CA$2.8m
Comprehensive Healthcare Systems
Symbol:
TSXV:CHS
Market cap:
CA$12.2m
Braxia Scientific
Symbol:
CNSX:BRAX
Market cap:
CA$1.4m
Nova Leap Health
Symbol:
TSXV:NLH
Market cap:
CA$24.4m
Element Lifestyle Retirement
Symbol:
TSXV:ELM
Market cap:
CA$704.8k
View more competitors